Exact Mass: 437.1588
Exact Mass Matches: 437.1588
Found 96 metabolites which its exact mass value is equals to given mass value 437.1588
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7-(1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoranyl-8-methoxy-4-oxidanylidene-quinoline-3-carboxylic acid hydrochloride
Estromustine
Pazopanib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
jatropham 5-O-3)-beta-D-glucopyranoside>|Jatropham 5-O-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranoside
Pazopanib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
Cys Cys Gly Arg
Cys Cys Arg Gly
Cys Gly Cys Arg
Cys Gly Arg Cys
Cys Asn Thr Thr
Cys Gln Ser Thr
Cys Gln Thr Ser
Cys Arg Cys Gly
Cys Arg Gly Cys
Cys Ser Gln Thr
Cys Ser Thr Gln
Cys Thr Asn Thr
Cys Thr Gln Ser
Cys Thr Ser Gln
Cys Thr Thr Asn
Gly Cys Cys Arg
Gly Cys Arg Cys
Gly Arg Cys Cys
Met Asn Ser Ser
Met Ser Asn Ser
Met Ser Ser Asn
Asn Cys Thr Thr
Asn Met Ser Ser
Asn Ser Met Ser
Asn Ser Ser Met
Asn Thr Cys Thr
Asn Thr Thr Cys
Gln Cys Ser Thr
Gln Cys Thr Ser
Gln Ser Cys Thr
Gln Ser Thr Cys
Gln Thr Cys Ser
Gln Thr Ser Cys
Arg Cys Cys Gly
Arg Cys Gly Cys
Arg Gly Cys Cys
Ser Cys Gln Thr
Ser Cys Thr Gln
Ser Met Asn Ser
Ser Met Ser Asn
Ser Asn Met Ser
Ser Asn Ser Met
Ser Gln Cys Thr
Ser Gln Thr Cys
Ser Ser Met Asn
Ser Ser Asn Met
Ser Thr Cys Gln
Ser Thr Gln Cys
Thr Cys Asn Thr
Thr Cys Gln Ser
Thr Cys Ser Gln
Thr Cys Thr Asn
Thr Asn Cys Thr
Thr Asn Thr Cys
Thr Gln Cys Ser
Thr Gln Ser Cys
Thr Ser Cys Gln
Thr Ser Gln Cys
Thr Thr Cys Asn
Thr Thr Asn Cys
Moxifloxacin HCl
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS